论文部分内容阅读
研制有效的肝细胞癌生物治疗制剂 ,作为现有治疗手段的有益补充或替代 ,具有重大的社会和经济效益。采用腺病毒溶瘤策略开展肝细胞癌的基因治疗研究是一个新的方向。文章概述了此方向研究所面临的问题 ,并提出了一些设想。
The development of effective biological treatment of hepatocellular carcinoma preparations, as a useful complement to the existing treatment or alternative, with significant social and economic benefits. Adopting adenovirus oncolytic strategy for hepatocellular carcinoma gene therapy research is a new direction. The article outlines the problems faced by this direction study and proposes some ideas.